Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Interest Expenses (2020 - 2024)

Historic Interest Expenses for Gyre Therapeutics (GYRE) over the last 10 years, with Q1 2024 value amounting to $315000.0.

  • Gyre Therapeutics' Interest Expenses fell 5101.09% to $315000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $315000.0, marking a year-over-year decrease of 5101.09%. This contributed to the annual value of $2.6 million for FY2023, which is 8879.18% up from last year.
  • Gyre Therapeutics' Interest Expenses amounted to $315000.0 in Q1 2024, which was down 5101.09% from $643000.0 recorded in Q1 2023.
  • Gyre Therapeutics' 5-year Interest Expenses high stood at $643000.0 for Q1 2023, and its period low was $7000.0 during Q3 2020.
  • Moreover, its 3-year median value for Interest Expenses was $182500.0 (2020), whereas its average is $253750.0.
  • Data for Gyre Therapeutics' Interest Expenses shows a peak YoY increase of 5101.09% (in 2024) and a maximum YoY decrease of 5101.09% (in 2024) over the last 5 years.
  • Over the past 3 years, Gyre Therapeutics' Interest Expenses (Quarter) stood at $50000.0 in 2020, then skyrocketed by 1186.0% to $643000.0 in 2023, then crashed by 51.01% to $315000.0 in 2024.
  • Its last three reported values are $315000.0 in Q1 2024, $643000.0 for Q1 2023, and $50000.0 during Q4 2020.